Abstract
Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-α (TNF-α) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-α antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome.
This is a preview of subscription content, log in via an institution to check access.
References
YT Konttinen et al (2005) Management of rheumatic diseases in the era of biological anti-rheumatic drugs. Acta Orthop 76:614–619
Berman JD (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684–703 (Apr)
Ho JL et al (1994) Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapy. Biotherapy 7:223–235
Green SJ et al (1990) Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol 144:278–283 (Jan 1)
Tak PP et al (1996) Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39:1077–1081 (Jul)
Paleolog EM, Fava RA (1998) Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies. Springer Semin Immunopathol 20:73–94
Rosenthal E et al (1995) Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 89:159–162 (Mar–Apr)
Baixauli Rubio A et al (2003) Rare opportunistic disease in a patient treated with immunosuppressive therapy for rheumatoid arthritis (in Spanish). An Med Interna 20:276–277 (May)
Wallis RS et al (2004) Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 39:1254–1255 (Oct 15)
Fabre S et al (2005) Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol 23:891–892 (Nov–Dec)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bagalas, V., Kioumis, I., Argyropoulou, P. et al. Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept. Clin Rheumatol 26, 1344–1345 (2007). https://doi.org/10.1007/s10067-006-0356-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-006-0356-5